Published in Immunology on April 12, 2007
Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol (2008) 1.48
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukoc Biol (2008) 1.23
Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy? World J Stem Cells (2015) 0.93
Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model. Immunology (2008) 0.90
Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application. Clin Dev Immunol (2013) 0.79
Adoptive Transfer of Dendritic Cells Expressing Fas Ligand Modulates Intestinal Inflammation in a Model of Inflammatory Bowel Disease. J Clin Cell Immunol (2016) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 28.73
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol (2004) 3.41
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
CTLA-4 regulates induction of anergy in vivo. Immunity (2001) 2.39
Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood (2004) 1.84
Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun (1997) 1.81
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol (2003) 1.59
Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood (2004) 1.35
Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol (1999) 1.34
Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes (1999) 1.27
Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med (2004) 1.25
Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species. Lab Anim Sci (1999) 1.24
Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res (2003) 1.24
Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol (2000) 1.21
Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol (2001) 1.17
Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes (2005) 1.10
Recent advances in dendritic cell biology. J Clin Immunol (2005) 1.08
Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur J Immunol (2002) 1.07
IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol (2002) 1.04
Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology (2002) 1.04
Intestinal flora and mucosal immune responses. Int J Med Microbiol (2003) 1.02
Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol (2004) 1.00
Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Res Immunol (1998) 0.98
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology (2000) 0.97
Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis. Clin Exp Immunol (2002) 0.95
Dendritic cells in peripheral tolerance and immunity. APMIS (2003) 0.90
Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood (2005) 0.89
Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells. Eur J Immunol (2004) 0.86
Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis (2005) 0.86
Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice. Int Immunol (2006) 0.78
Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.21
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis (2009) 1.58
The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. J Antimicrob Chemother (1987) 1.42
[Gaucher disease, Fabry disease and mucopolysaccharidosis type I--how can the rheumatologist recognise these patients?]. Z Rheumatol (2006) 1.42
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis (2009) 1.30
Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol (1994) 1.21
Nonrespiratory side effects of epidural morphine. Anesth Analg (1982) 1.20
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Light and electron microscopic studies of the paracortical post-capillary high-endothelial venules. Z Zellforsch Mikrosk Anat (1971) 1.13
The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am J Pathol (2000) 1.12
Altered bacterial profiles in saliva from adults with caries lesions: a case-cohort study. Caries Res (2014) 1.06
Propionic acidemia: neonatal versus selective metabolic screening. J Inherit Metab Dis (2011) 1.05
Indirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy. Gene Ther (2010) 1.05
Identifying cytotoxic T cell epitopes from genomic and proteomic information: "The human MHC project.". Rev Immunogenet (2000) 1.05
Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome. Clin Exp Rheumatol (2006) 1.05
Isolation and characterization of a growth-cycle-reflecting, high-molecular-weight protein associated with Escherichia coli ribosomes. Eur J Biochem (1976) 1.03
Selective engraftment of memory CD4+ T cells with an unusual recirculation pattern and a diverse T cell receptor-V beta repertoire into scid mice. Eur J Immunol (1993) 1.02
Rostral spread of epidural morphine. Anesthesiology (1982) 0.99
MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination. Arch Virol (2008) 0.98
Mechanical properties of the human Achilles tendon, in vivo. Clin Biomech (Bristol, Avon) (2011) 0.96
MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis. J Immunol (1997) 0.96
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1995) 0.94
Preoperative segmental localization of hepatic metastases: utility of three-dimensional CT during arterial portography. Radiology (1991) 0.94
Selective reconstitution of T lymphocyte subsets in scid mice. Immunol Rev (1991) 0.94
Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis (2011) 0.93
Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4. Cancer Lett (2005) 0.93
CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice. Eur J Immunol (1991) 0.92
Evaluation of respiratory inductive plethysmography in controlled ventilation: measurement of tidal volume and PEEP-induced changes of end-expiratory lung volume. Chest (1998) 0.92
Quantitative studies on the decay of lymphoid cells during the development of casein-induced murine amyloidosis. Acta Pathol Microbiol Scand A (1972) 0.91
Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol (2009) 0.90
Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicity. Scand J Immunol (2001) 0.90
Immunobiological effects of glucosamine in vitro. Scand J Immunol (2003) 0.90
Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity. Eur J Immunol (2001) 0.90
Histochemistry and development of the human eyelids. II. A cytochemical and electron microscopical study. Acta Ophthalmol (Copenh) (1967) 0.89
Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health (2001) 0.89
Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur J Immunol (1998) 0.89
Treatment of an immortalized APC cell line with both cytokines and LPS ensures effective T-cell activation in vitro. Scand J Immunol (2002) 0.89
Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood (1998) 0.89
Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitis. Eur J Immunol (1996) 0.89
Self-peptides with intermediate capacity to bind and stabilize MHC class I molecules may be immunogenic. Scand J Immunol (2003) 0.89
In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells. Cancer Immunol Immunother (1994) 0.88
High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination. Clin Exp Immunol (2009) 0.87
Characterization of monocyte-derived dendritic cells maturated with IFN-alpha. Scand J Immunol (2006) 0.87
A gut-homing, oligoclonal CD4+ T cell population in severe-combined immunodeficient mice expressing a rearranged, transgenic class I-restricted alpha beta T cell receptor. Eur J Immunol (1995) 0.87
Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. J Immunol (1996) 0.86
Evidence for gas nuclei in decompressed rats. Undersea Biomed Res (1980) 0.86
MHC class I signaling in T cells leads to tyrosine kinase activity and PLC-gamma 1 phosphorylation. J Immunol (1995) 0.86
CD3+ T-cells in severe combined immunodeficiency (scid) mice. III. Transferred congenic, selfreactive CD4+ T cell clones rescue IgM-producing, scid-derived B cells. Int Immunol (1991) 0.86
Compliance with universal precautions among emergency department personnel caring for trauma patients. Ann Emerg Med (1999) 0.85
Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination. Scand J Immunol (2005) 0.85
Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein. Scand J Immunol (2000) 0.85
Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol Immunother (1995) 0.85
Compliance with Universal Precautions among emergency department personnel: implications for prevention programs. Am J Infect Control (1999) 0.85
In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts. Clin Exp Immunol (1999) 0.84
B lymphocyte colony-forming cells in the SJL/J mouse. J Immunol (1977) 0.84
Tumour necrosis factor-alpha (TNF-alpha) transcription and translation in the CD4+ T cell-transplanted scid mouse model of colitis. Clin Exp Immunol (1999) 0.84
Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production. Scand J Immunol (2001) 0.84
Fast generation of dendritic cells. Cell Immunol (2009) 0.84
Signal transduction by the major histocompatibility complex class I molecule. APMIS (1999) 0.83
Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells. Rheumatology (Oxford) (2008) 0.83
T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex. Immunology (1989) 0.83
T cell-mediated cytotoxicity against p53-protein derived peptides in bulk and limiting dilution cultures of healthy donors. Scand J Immunol (1995) 0.83
Histology of the induction phase of the primary immune response in lymph nodes of germfree mice. Acta Pathol Microbiol Scand A (1971) 0.83
T-cell transfer and cytokine/TCR gene deletion models in the study of inflammatory bowel disease. APMIS (1997) 0.83
C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro. Int Immunol (1998) 0.83
The veto phenomenon in T-cell regulation. Ann N Y Acad Sci (1988) 0.82
T-cell activation. IV. Evidence for a functional linkage between MHC class I, interleukin-2 receptor, and interleukin-4 receptor molecules. Cytokine (1991) 0.82
Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 0.82
Reconstitution of SCID mice with low numbers of CD4+ TCR alpha beta + T cells. Res Immunol (1994) 0.82
Social outcome in treated individuals with inherited metabolic disorders: UK study. J Inherit Metab Dis (2005) 0.82
Immunoglobulin leakiness in scid mice with CD4(+) T-cell-induced chronic colitis. Clin Immunol (2000) 0.82
Radically altered T cell receptor signaling in glycopeptide-specific T cell hybridoma induced by antigen with minimal differences in the glycan group. Eur J Immunol (2001) 0.82
CD4+ T regulatory cells from the colonic lamina propria of normal mice inhibit proliferation of enterobacteria-reactive, disease-inducing Th1-cells from scid mice with colitis. Clin Exp Immunol (2003) 0.81
Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Clin Exp Immunol (2015) 0.81
Proliferation and apoptosis of lamina propria CD4+ T cells from scid mice with inflammatory bowel disease. Eur J Immunol (1998) 0.81
Comparative studies of the paracortical post-capillary venules of normal and nude mice. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 0.81
Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease. J Mol Med (Berl) (1995) 0.81
Systemic adverse events following rituximab therapy in patients with Graves' disease. J Endocrinol Invest (2010) 0.81
Genome-wide gene expression profiling of SCID mice with T-cell-mediated Colitis. Scand J Immunol (2009) 0.81
T cell activation. II. Activation of human T lymphoma cells by cross-linking of their MHC class I antigens. Cell Immunol (1990) 0.81
Immunotoxicity of the pyrethroid insecticides deltametrin and alpha-cypermetrin. Toxicology (1996) 0.80
Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice. Clin Exp Immunol (2013) 0.80
The influence of the hair follicle phase on the survival time of skin allografts in the mouse. Transplantation (1970) 0.80
Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors. Vaccine (2009) 0.80
Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis. Scand J Immunol (2009) 0.80
The complement system and its role in the pathogenesis of periodontitis: current concepts. J Periodontal Res (2014) 0.80
Cerebral hemodynamics during induced tachycardia in routine electrophysiologic studies: a transcranial Doppler study. Neurol Res (1998) 0.80
Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes. Rheumatol Int (2014) 0.79
Meteorotropy and medical-meteorological forecasts. Experientia (1993) 0.79
Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells. Scand J Gastroenterol (2000) 0.79
The impact of Pseudomonas syringae type III effectors on transient protein expression in tobacco. Plant Biol (Stuttg) (2014) 0.79
Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery. Scand Cardiovasc J (1997) 0.79
Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line. Int J Cancer (2001) 0.79
In vitro cytokine responses to periodontal pathogens: generalized aggressive periodontitis is associated with increased IL-6 response to Porphyromonas gingivalis. Scand J Immunol (2010) 0.79